{"log_id": 5779579776801560123, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 7.4e-05, "average": 0.995317, "min": 0.970601}, "location": {"width": 284, "top": 159, "height": 28, "left": 114}, "words": "核准日期:2007年02月14日"}, {"probability": {"variance": 0.000564, "average": 0.989386, "min": 0.904922}, "location": {"width": 283, "top": 197, "height": 27, "left": 114}, "words": "修改日期:2008年11月17日"}, {"probability": {"variance": 0.000213, "average": 0.990796, "min": 0.952312}, "location": {"width": 286, "top": 234, "height": 31, "left": 114}, "words": "修改日期:2014年06月28日"}, {"probability": {"variance": 0.001917, "average": 0.981169, "min": 0.843824}, "location": {"width": 553, "top": 259, "height": 62, "left": 294}, "words": "注射用盐酸伊立康说明书"}, {"probability": {"variance": 1e-06, "average": 0.999243, "min": 0.99666}, "location": {"width": 486, "top": 342, "height": 33, "left": 341}, "words": "请仔细阅读说明书并在医师指导下使用"}, {"probability": {"variance": 1e-06, "average": 0.999015, "min": 0.997224}, "location": {"width": 99, "top": 400, "height": 23, "left": 120}, "words": "【药品名称】"}, {"probability": {"variance": 3.2e-05, "average": 0.996928, "min": 0.978212}, "location": {"width": 260, "top": 428, "height": 25, "left": 150}, "words": "通用名称:注射用盐酸伊立替康"}, {"probability": {"variance": 0, "average": 0.999634, "min": 0.999036}, "location": {"width": 130, "top": 462, "height": 22, "left": 151}, "words": "商品名称:艾力"}, {"probability": {"variance": 8.5e-05, "average": 0.993506, "min": 0.975326}, "location": {"width": 106, "top": 493, "height": 23, "left": 150}, "words": "英文名称:Ir"}, {"probability": {"variance": 0.000665, "average": 0.965969, "min": 0.931116}, "location": {"width": 162, "top": 494, "height": 20, "left": 322}, "words": " Hydrochloride for Inje"}, {"probability": {"variance": 0.005065, "average": 0.949727, "min": 0.821418}, "location": {"width": 109, "top": 523, "height": 23, "left": 150}, "words": "汉语拼音:Zh"}, {"probability": {"variance": 0, "average": 0.999169, "min": 0.999169}, "location": {"width": 16, "top": 526, "height": 16, "left": 338}, "words": " Ya"}, {"probability": {"variance": 5e-06, "average": 0.998055, "min": 0.994417}, "location": {"width": 101, "top": 553, "height": 25, "left": 119}, "words": "【成份】"}, {"probability": {"variance": 6.4e-05, "average": 0.996796, "min": 0.960916}, "location": {"width": 394, "top": 582, "height": 25, "left": 157}, "words": "本品主要成份是盐酸伊立替康。其化学名称为(+"}, {"probability": {"variance": 0.020194, "average": 0.909804, "min": 0.573363}, "location": {"width": 350, "top": 582, "height": 25, "left": 706}, "words": "二乙基一4一羟基9一[(4一哌啶基哌啶)羰"}, {"probability": {"variance": 0.01256, "average": 0.924431, "min": 0.593454}, "location": {"width": 128, "top": 616, "height": 23, "left": 116}, "words": "基]-1H-吡喃并[3"}, {"probability": {"variance": 0.014012, "average": 0.926312, "min": 0.546958}, "location": {"width": 284, "top": 615, "height": 21, "left": 315}, "words": "7吲哚嗪[1,2b]喹啉-3,14-(4H"}, {"probability": {"variance": 0.002079, "average": 0.974987, "min": 0.848512}, "location": {"width": 165, "top": 614, "height": 22, "left": 689}, "words": "二酮盐酸盐三水合物"}, {"probability": {"variance": 1.1e-05, "average": 0.998109, "min": 0.98935}, "location": {"width": 131, "top": 645, "height": 24, "left": 152}, "words": "其化学结构式为:"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 530, "top": 680, "height": 113, "left": 105}, "words": " 6k9-oyy"}, {"probability": {"variance": 0.002429, "average": 0.936579, "min": 0.879823}, "location": {"width": 100, "top": 740, "height": 20, "left": 795}, "words": " HCI, 3H20"}, {"probability": {"variance": 0, "average": 0.908844, "min": 0.908844}, "location": {"width": 14, "top": 767, "height": 18, "left": 779}, "words": "0"}, {"probability": {"variance": 0.022042, "average": 0.68622, "min": 0.537755}, "location": {"width": 106, "top": 788, "height": 21, "left": 693}, "words": " RO CH"}, {"probability": {"variance": 0.040734, "average": 0.867459, "min": 0.359116}, "location": {"width": 272, "top": 830, "height": 26, "left": 149}, "words": "分子式:C3H3NO6·HC1·3H20"}, {"probability": {"variance": 0.000157, "average": 0.992585, "min": 0.958311}, "location": {"width": 137, "top": 864, "height": 23, "left": 151}, "words": "分子量:677.19"}, {"probability": {"variance": 1.1e-05, "average": 0.998181, "min": 0.98878}, "location": {"width": 178, "top": 892, "height": 23, "left": 156}, "words": "其辅料为乳酸和甘露醇"}, {"probability": {"variance": 0.000131, "average": 0.989275, "min": 0.96981}, "location": {"width": 98, "top": 920, "height": 24, "left": 120}, "words": "【性状】"}, {"probability": {"variance": 0.001829, "average": 0.9882, "min": 0.81203}, "location": {"width": 331, "top": 948, "height": 24, "left": 151}, "words": "本品为淡黄色至黄色的疏松块状物或粉末"}, {"probability": {"variance": 6e-06, "average": 0.998178, "min": 0.99331}, "location": {"width": 100, "top": 978, "height": 23, "left": 120}, "words": "【适应症】"}, {"probability": {"variance": 0.003822, "average": 0.983313, "min": 0.614926}, "location": {"width": 695, "top": 1003, "height": 28, "left": 150}, "words": "用于成人转移性大肠癌的治疗,对于经含5一Fu化疗失败的患者,本品可作为二线治疗"}, {"probability": {"variance": 0.010346, "average": 0.94045, "min": 0.764278}, "location": {"width": 100, "top": 1035, "height": 24, "left": 120}, "words": "【规格】"}, {"probability": {"variance": 0.023348, "average": 0.918293, "min": 0.439405}, "location": {"width": 279, "top": 1061, "height": 29, "left": 171}, "words": "1)40mg(按C3H38N4O6·HCl计)"}, {"probability": {"variance": 0.010789, "average": 0.939585, "min": 0.600361}, "location": {"width": 296, "top": 1062, "height": 22, "left": 532}, "words": "(2)100mg(按C33H38N4O6·HCl计)"}, {"probability": {"variance": 1e-05, "average": 0.996851, "min": 0.991701}, "location": {"width": 99, "top": 1092, "height": 23, "left": 120}, "words": "【用法用量】"}, {"probability": {"variance": 4e-05, "average": 0.995995, "min": 0.970421}, "location": {"width": 524, "top": 1118, "height": 26, "left": 151}, "words": "本品推荐剂量为350mg/m2,静脉滴注30~90分钟,每三周一次"}, {"probability": {"variance": 0, "average": 0.999573, "min": 0.998946}, "location": {"width": 77, "top": 1150, "height": 23, "left": 151}, "words": "剂量调整"}, {"probability": {"variance": 0.000593, "average": 0.991736, "min": 0.830203}, "location": {"width": 903, "top": 1174, "height": 27, "left": 151}, "words": "对于无症状的严重中性粒细胞减少症(中性粒细胞计数<500/mm3),中性粒细胞减少伴发热或感染(体温超过"}, {"probability": {"variance": 0.003847, "average": 0.979138, "min": 0.584604}, "location": {"width": 937, "top": 1203, "height": 26, "left": 117}, "words": "38℃,中性粒细胞计数<1000/mm3),或严重腹泻(需静脉输液治疗)的病人,下周期治疗剂量应从350mg/m2减至"}, {"probability": {"variance": 3.3e-05, "average": 0.99615, "min": 0.975448}, "location": {"width": 935, "top": 1232, "height": 26, "left": 118}, "words": "300mg/m2,若这一剂量仍出现严重中性粒细胞减少症,或如上所述的与中性粒细胞减少相关的发热及感染或严重腹泻"}, {"probability": {"variance": 2.1e-05, "average": 0.997577, "min": 0.978408}, "location": {"width": 520, "top": 1262, "height": 25, "left": 115}, "words": "时,下一周期治疗剂量可进一步从300mg/m2减量至250mg/m2"}, {"probability": {"variance": 6.2e-05, "average": 0.994849, "min": 0.981236}, "location": {"width": 74, "top": 1293, "height": 22, "left": 154}, "words": "延迟给药"}, {"probability": {"variance": 0.000204, "average": 0.994582, "min": 0.900259}, "location": {"width": 903, "top": 1318, "height": 26, "left": 151}, "words": "患者中性粒细胞计数未恢复至1500/mm3以上前请勿使用本品。当患者曾出现过严重中性粒细胞减少症或严重胃"}, {"probability": {"variance": 0.000478, "average": 0.992786, "min": 0.862823}, "location": {"width": 801, "top": 1348, "height": 26, "left": 116}, "words": "肠道的不良反应如腹泻、恶心和呕吐时,本品的使用必须推迟到这些症状,尤其是腹泻完全消失为止"}, {"probability": {"variance": 1.7e-05, "average": 0.995666, "min": 0.99158}, "location": {"width": 42, "top": 1381, "height": 21, "left": 151}, "words": "疗程"}, {"probability": {"variance": 0.000194, "average": 0.99542, "min": 0.922559}, "location": {"width": 530, "top": 1406, "height": 24, "left": 152}, "words": "本药应持续使用直到出现客观的病变进展或难以承受的毒性时停药"}, {"probability": {"variance": 1e-06, "average": 0.998899, "min": 0.997737}, "location": {"width": 76, "top": 1436, "height": 23, "left": 151}, "words": "特殊人群"}, {"probability": {"variance": 0.000139, "average": 0.994654, "min": 0.939569}, "location": {"width": 904, "top": 1462, "height": 26, "left": 151}, "words": "肝功能受损的患者:当患者的胆红素超过正常值上限(UN)的1.0~1.5倍时,发生重度中性粒细胞减少症的可能"}, {"probability": {"variance": 0.001089, "average": 0.991212, "min": 0.769797}, "location": {"width": 832, "top": 1492, "height": 26, "left": 116}, "words": "性增加。对该人群应经常进行全血细胞计数。当患者的胆红素超过正常值上限1.5倍时,不可用本品治疗"}, {"probability": {"variance": 0.002979, "average": 0.982377, "min": 0.74602}, "location": {"width": 421, "top": 1521, "height": 26, "left": 152}, "words": "肾功能受损的患者:本品不宜用于肾功能不良的患者"}, {"probability": {"variance": 5e-06, "average": 0.998595, "min": 0.987861}, "location": {"width": 895, "top": 1551, "height": 24, "left": 152}, "words": "老年人:未对老年人进行过特殊药代动力学研究。但是,由于老年人各项生理功能,尤其是肝功能的减退机率很大"}, {"probability": {"variance": 0.000793, "average": 0.987291, "min": 0.91305}, "location": {"width": 148, "top": 1581, "height": 23, "left": 115}, "words": "选择剂量时须谨慎"}], "language": 3}